An examination of HIV/AIDS patients who have excellent adherence to HAART

被引:96
作者
Malcolm, SE
Ng, JJ
Rosen, RK
Stone, VE
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gen Internal Med Unit, Boston, MA 02114 USA
[2] Mem Hosp Rhode Isl, Dept Med, Pawtucket, RI 02860 USA
[3] Rhode Isl Hosp, Providence, RI 02903 USA
[4] Brown Med Sch, Providence, RI USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2003年 / 15卷 / 02期
关键词
D O I
10.1080/0954012031000068399
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This paper examines the attitudes and beliefs of HIV/AIDS patients with excellent adherence to highly active antiretroviral therapy (HAART) and how they differ from those with suboptimal adherence. Forty-four persons with HIV/AIDS, 28 men and 16 women, participated in a qualitative semi-structured interview which was based on the Health Belief Model. The main outcomes were themes consistent with several dimensions of this model, reflecting differences in the health-related attitudes and beliefs of the excellent adherers compared to the suboptimal adherers. Patients with excellent adherence voiced the following themes when compared to less adherent patients: (1) believed adherence rates needed to be 90-100% for medication efficacy; (2) trusted their primary providers greatly; (3) took medications even when actively using substances of abuse; (4) were open about their HIV status and received substantial social support; (5) cited staying healthy as their key motivator; (6) were not actively depressed; all had normal CESD scores. Our study suggests that patients with excellent adherence to HAART differ from their less adherent counterparts in terms of key health-related attitudes and beliefs. Identifying and studying excellent adherers provides new insights and strategies for enhancing adherence to HAART.
引用
收藏
页码:251 / 261
页数:11
相关论文
共 26 条
[1]  
ANDREWS L, 2000, 13 INT AIDS C DURB S
[2]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[3]   When should we delay highly active antiretroviral therapy? [J].
Bangsberg, DR ;
Moss, A .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1999, 14 (07) :446-448
[4]  
Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005
[5]  
BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121
[6]   Self-reported antiretroviral therapy in injection drug users [J].
Celentano, DD ;
Vlahov, D ;
Cohn, S ;
Shadle, VM ;
Obasanjo, O ;
Moore, RD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06) :544-546
[7]  
CHEEVER L, 1999, WORKSH FOR COLL HIV
[8]   Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107
[9]   Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease [J].
Eldred, LJ ;
Wu, AW ;
Chaisson, RE ;
Moore, RD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) :117-125
[10]  
Friedland GH, 1999, AIDS, V13, pS61